ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut

March 15, 1985

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

Moses To Lead AACI.

October 19, 2001

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998